Charles Schwab’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-129,927
Closed -$3.99M 3597
2022
Q4
$3.99M Buy
129,927
+1,810
+1% +$57.1K ﹤0.01% 2329
2022
Q3
$4.38M Buy
128,117
+48,736
+61% +$2.09M ﹤0.01% 2282
2022
Q2
$2.75M Buy
79,381
+1,725
+2% +$60.8K ﹤0.01% 2458
2022
Q1
$3.42M Sell
77,656
-1,449
-2% -$70.1K ﹤0.01% 2462
2021
Q4
$4.97M Buy
79,105
+2,565
+3% +$217K ﹤0.01% 2358
2021
Q3
$8.07M Buy
76,540
+1,625
+2% +$233K ﹤0.01% 2131
2021
Q2
$13.3M Sell
74,915
-10,934
-13% -$1.76M ﹤0.01% 1850
2021
Q1
$11.5M Buy
85,849
+2,867
+3% +$444K ﹤0.01% 1880
2020
Q4
$11.2M Buy
82,982
+2,825
+4% +$288K ﹤0.01% 1794
2020
Q3
$6.67M Buy
+80,157
New +$6.43M ﹤0.01% 1928

Other funds holding ZLAB

Charles Schwab's ZLAB Position: Q1 2023 in Review

Charles Schwab sold out of Zai Lab (ZLAB) in Q1 2023, closing a stake of 129,927 shares — an estimated $3.99M sold.

Charles Schwab first reported a position in ZLAB in Q3 2020 and held it in 10 quarters. The position peaked at $13.3M in Q2 2021. 160 funds tracked by Wall St. Rank hold ZLAB as of Q1 2023.

  • Charles Schwab reported no remaining Zai Lab position as of Q1 2023 after selling out during the quarter.
  • Charles Schwab sold 129,927 Zai Lab shares in Q1 2023, an estimated $3.99M.
  • Charles Schwab first reported a position in Zai Lab in Q3 2020 and held it in 10 quarters.
  • Charles Schwab's Zai Lab position peaked at $13.3M in Q2 2021.
  • 160 funds tracked by Wall St. Rank held Zai Lab as of Q1 2023.

Based on Charles Schwab's 13F filing for Q1 2023, filed 12 May 2023.